RHUMBLINE ADVISERS - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 163 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,456
-98.4%
3,600
-97.8%
0.00%
Q1 2022$210,000
-60.2%
162,991
-60.7%
0.00%
-100.0%
Q4 2021$527,000
-40.2%
414,797
+2.5%
0.00%0.0%
Q3 2021$882,000
-47.8%
404,538
-10.2%
0.00%
-50.0%
Q2 2021$1,690,000
+2.9%
450,550
-10.6%
0.00%0.0%
Q1 2021$1,643,000
-2.1%
503,919
+2.3%
0.00%0.0%
Q4 2020$1,679,000
-3.7%
492,479
+15.3%
0.00%
-33.3%
Q3 2020$1,743,000
+33.6%
427,223
+10.7%
0.00%
+50.0%
Q2 2020$1,305,000
+48.1%
385,979
+2.1%
0.00%0.0%
Q1 2020$881,000
-32.7%
378,019
+5.1%
0.00%0.0%
Q4 2019$1,309,000
-53.0%
359,681
+7.1%
0.00%
-60.0%
Q3 2019$2,787,000
+1.9%
335,955
+5.7%
0.01%0.0%
Q2 2019$2,735,000
-13.4%
317,691
+7.5%
0.01%
-16.7%
Q1 2019$3,160,000
+24.7%
295,596
+2.0%
0.01%0.0%
Q4 2018$2,535,000
-35.3%
289,725
+24.2%
0.01%
-25.0%
Q3 2018$3,919,000
-19.0%
233,254
+1.0%
0.01%
-20.0%
Q2 2018$4,839,000
+38.5%
230,884
+6.4%
0.01%
+42.9%
Q1 2018$3,493,000
-12.5%
217,072
+3.1%
0.01%
-12.5%
Q4 2017$3,992,000
+73.1%
210,642
+28.5%
0.01%
+60.0%
Q3 2017$2,306,000
+97.9%
163,884
+4.8%
0.01%
+66.7%
Q2 2017$1,165,000
+19.0%
156,334
+3.8%
0.00%
+50.0%
Q1 2017$979,000
+101.4%
150,580
+37.4%
0.00%
+100.0%
Q4 2016$486,000
-5.1%
109,596
+0.0%
0.00%0.0%
Q3 2016$512,000
-19.7%
109,584
+12.8%
0.00%
-50.0%
Q2 2016$638,000
-11.0%
97,129
-13.8%
0.00%0.0%
Q1 2016$717,000
+13.4%
112,685
+7.6%
0.00%0.0%
Q4 2015$632,000
+7.5%
104,755
+6.5%
0.00%0.0%
Q3 2015$588,000
-7.3%
98,355
+6.2%
0.00%0.0%
Q2 2015$634,000
+3.3%
92,645
-8.4%
0.00%0.0%
Q1 2015$614,000
-6.3%
101,125
+6.9%
0.00%0.0%
Q4 2014$655,000
-8.8%
94,575
+7.2%
0.00%0.0%
Q3 2014$718,000
+0.7%
88,250
+0.6%
0.00%0.0%
Q2 2014$713,0000.0%87,750
-3.5%
0.00%0.0%
Q1 2014$713,000
-13.9%
90,944
-2.8%
0.00%0.0%
Q4 2013$828,000
-1.4%
93,564
-6.5%
0.00%
-33.3%
Q3 2013$840,000
+14.0%
100,114
+1.4%
0.00%
+50.0%
Q2 2013$737,00098,7690.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders